Kardiologie up2date 2009; 5(3): 213-218
DOI: 10.1055/s-0029-1215078
Koronare Herzerkrankung und Atherosklerose

© Georg Thieme Verlag KG Stuttgart · New York

Neue Biomarker im akuten Koronarsyndrom

Tanja  K.  Rudolph, Volker  Rudolph, Stephan  Baldus
Further Information

Publication History

Publication Date:
15 October 2009 (online)

Abstract

Patients presenting with acute coronary syndromes still represent a high risk population in whom early risk assessment is of essential importance to guide therapy. Besides clinical symptoms and ECG criteria cardiac biomarkers have emerged as critical tools for risk stratification. Whereas troponins remain the most validated biomarkers used in clinical practice today, current research aims to identify novel markers which are capable of indentifying patients at risk at an earlier stage of the disease, that ist prior to myocardial damage.

Literatur

Dr. med. Tanja K. Rudolph

Klinik für Allgemeine und Interventionelle Kardiologie
Universitäres Herzzentrum Hamburg
Universitätsklinikum Hamburg-Eppendorf

Martinistr. 52
20246 Hamburg

Email: t.rudolph@uke.de